Related Experiment Video
Updated: Jun 20, 2026
07:47
Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System
Published on: October 29, 2019
RNAi applications in therapy development for neurodegenerative disease
1MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital and Harvard, Medical School, 114 16th Street, Room 3200, Charlestown, MA 02129, USA. mmmaxwell@partners.org
Current Pharmaceutical Design
|September 16, 2009
Summary
RNA-mediated interference (RNAi) offers a powerful method for gene silencing, showing promise for treating neurodegenerative diseases like Alzheimer's and Parkinson's. RNAi also aids in identifying drug targets for neurological conditions.
Area of Science:
- Molecular Biology
- Neuroscience
- Genetics
Background:
- RNA-mediated interference (RNAi) is a natural gene silencing mechanism.
- RNAi uses double-stranded RNA to degrade specific messenger RNAs.
- This technology is crucial for understanding gene function in various models.
Purpose of the Study:
- To review RNAi therapeutics for neurodegenerative diseases.
- To discuss challenges of RNAi delivery in the central nervous system (CNS).
- To highlight RNAi's role in drug target identification and validation for neurological disorders.
Main Methods:
- Review of preclinical RNAi therapeutic development.
- Analysis of RNAi applications in target identification and validation.
- Discussion of CNS-specific challenges for RNAi-based therapies.
Main Results:
- RNAi holds significant therapeutic potential for neurodegenerative diseases.
- RNAi is a valuable tool for identifying and validating drug targets.
- Central nervous system delivery remains a key challenge for RNAi therapeutics.
Conclusions:
- RNAi-based therapies show promise for treating neurodegenerative diseases.
- RNAi is instrumental in advancing drug discovery for neurological conditions.
- Overcoming CNS delivery hurdles is critical for realizing RNAi's full therapeutic potential.
Related Concept Videos
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
02:23RNA Editing
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...